Europe pharmaceutical analytical testing outsourcing market was valued at $1,919.1 million in 2021 and will grow by 8.4% annually over 2021-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities.
Highlighted with 34 tables and 51 figures, this 109-page report Europe Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe pharmaceutical analytical testing outsourcing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe pharmaceutical analytical testing outsourcing market in every aspect of the classification from perspectives of Service Type, Product Type, End User, Organization Size, and Country.
Based on Service Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
o Clinical Testing
o Non-clinical Testing
Method Development and Validation
o Extractable & Leachable
o Impurity Method
o Technical Consulting
o Other Methods
o Drug Substances Testing
o Accelerated Stability Testing
o Photostability Testing
o Other Stability Testings
Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Raw Materials & Additives
Active Pharmaceutical Ingredients (APIs)
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Pharmaceutical & Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Other End Users
By Organization Size, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Geographically, the following national/local markets are fully investigated:
Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Service Type, End User and Organization Size over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Boston Analytical, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Exova Group PLC
Intertek Pharmaceutical Services
Laboratory Testing Inc.
Pace Analytical Services LLC
Pharmaceutical Product Development, LLC
West Pharmaceutical Services Inc.
WuXi AppTec, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)